Preimplantation Genetic Testing Market Size to Reach USD 1849.38 Million by 2032 – SNS Insider [Yahoo! Finance]
Illumina, Inc. (ILMN)
Last illumina, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
illumina.com/company/investor-information.html
Company Research
Source: Yahoo! Finance
2032, driven by rising IVF cycle volumes, increased awareness of genetic disorders, and rapid adoption of advanced embryo screening technologies. Austin, Nov. 18, 2025 (GLOBE NEWSWIRE) -- According to SNS Insider, the Preimplantation Genetic Testing Market was valued at USD 791.50 million in 2023 and is projected to reach USD 1849.38 million by 2032, growing at a CAGR of 9.93 percent during the forecast period from 2024 to 2032. The U.S. market alone was valued at USD 229.42 million in 2023 and is forecasted to expand to USD 528.43 million by 2032, with a CAGR of 9.76 percent. Get Free Sample Report of the Preimplantation Genetic Testing Market: https://www.snsinsider.com/sample-request/6298 Preimplantation genetic testing has become a vital component of modern fertility care. As infertility rates rise globally and more individuals pursue assisted reproductive technologies, the need for accurate and dependable genetic screening before embryo transfer continues to grow. These tes
Show less
Read more
Impact Snapshot
Event Time:
ILMN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ILMN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ILMN alerts
High impacting Illumina, Inc. news events
Weekly update
A roundup of the hottest topics
ILMN
News
- Illumina (NASDAQ:ILMN) had its "hold (c-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Illumina (NASDAQ:ILMN) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.MarketBeat
- Illumina (NASDAQ:ILMN) was upgraded by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from a "sell (d+)" rating to a "hold (c-)" rating.MarketBeat
- Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study [Yahoo! Finance]Yahoo! Finance
- Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature studyPR Newswire
ILMN
Earnings
- 10/30/25 - Beat
ILMN
Sec Filings
- 11/25/25 - Form 8-K
- 11/13/25 - Form SCHEDULE
- 11/12/25 - Form 8-K
- ILMN's page on the SEC website